Literature DB >> 27958284

Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.

H Vanheel1,2, F Carbone1,2, L Valvekens1, M Simren1, H Tornblom1, T Vanuytsel1, L Van Oudenhove1, J Tack1.   

Abstract

OBJECTIVES: The Rome III criteria proposed to subdivide functional dyspepsia (FD) into a postprandial distress syndrome (PDS) group, characterized by the presence of postprandial fullness and/or early satiety, and an epigastric pain syndrome (EPS) group, characterized by the presence of epigastric pain and/or epigastric burning. It has been suggested that different pathophysiological mechanisms underlie the symptom presentations in these subgroups that might determine treatment choices. The aim of this study was to investigate the prevalence of gastric sensorimotor dysfunction in the PDS, EPS, and overlap groups and to evaluate potential differential associations with dyspeptic symptom scores.
METHODS: Consecutive FD patients fulfilling Rome III criteria were recruited and they scored frequency of dyspeptic symptoms (postprandial fullness, early satiety, nausea, bloating, epigastric pain, and epigastric burning) over the past 3 months (0-5; 1=once a month or less, 2=two or three times a month, 3=once a week, 4=several times a week, 5=every day). The cumulative symptom score was calculated by adding up the score of these dyspeptic symptoms. Based on these symptom scores, the patients were subdivided into subgroups according to the Rome III consensus: (i) PDS, characterized by postprandial fullness and/or early satiety at least several times a week, (ii) EPS, characterized by epigastric pain and/or epigastric burning at least once a week, and (iii) overlap, fulfilling the criteria for both PDS and EPS. Gastric sensitivity and gastric accommodation were measured using barostat testing, and solid gastric emptying was determined using the [14C]octanoate breath test.
RESULTS: A total of 560 FD patients (165 men, age 41.8±0.7 years) were classified into PDS (n=131), EPS (n=50), and overlap (n=379) groups. The prevalence of gastric hypersensitivity, impaired gastric accommodation, and delayed gastric emptying were 37%, 37%, and 23%, respectively, without any differential distribution in Rome III subgroups (P=0.16, P=0.27, and P=0.39 respectively). Comparing the physiological parameters for these gastric sensorimotor functions, there was only a significant difference in the gastric half emptying time between subgroups, with the overlap group having a higher t1/2 (P<0.05) compared with the EPS group. In the overlap group, gastric hypersensitivity was associated with the severity of PDS symptoms (P=0.03), EPS symptoms (P=0.02), and the cumulative symptom score (P=0.02), whereas delayed gastric emptying was associated with nausea (P=0.02) and the cumulative symptom score (P=0.02).
CONCLUSIONS: Except for gastric emptying in the overlap group, FD subgroups as defined by the Rome III criteria are not differentially associated with putative pathophysiological mechanisms. These observations question the utility of this classification for guiding therapeutic choices in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27958284     DOI: 10.1038/ajg.2016.499

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  45 in total

1.  Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease.

Authors:  Tomotaka Shindo; Seiji Futagami; Tetsuro Hiratsuka; Akane Horie; Tatsuhiko Hamamoto; Nobue Ueki; Masafumi Kusunoki; Kazumasa Miyake; Katya Gudis; Taku Tsukui; Katsuhiko Iwakiri; Choitsu Sakamoto
Journal:  Digestion       Date:  2009-02-27       Impact factor: 3.216

2.  High frequency of overlap between functional dyspepsia and overactive bladder.

Authors:  J Matsuzaki; H Suzuki; Y Fukushima; K Hirata; S Fukuhara; S Okada; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2012-05-23       Impact factor: 3.598

3.  Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study.

Authors:  B Waldron; P T Cullen; R Kumar; D Smith; J Jankowski; D Hopwood; D Sutton; N Kennedy; F C Campbell
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

4.  Classification of functional dyspepsia based on concomitant bowel symptoms.

Authors:  J Matsuzaki; H Suzuki; K Asakura; Y Fukushima; J M Inadomi; T Takebayashi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2012-01-11       Impact factor: 3.598

Review 5.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Symptom pattern and pathophysiological correlates of weight loss in tertiary-referred functional dyspepsia.

Authors:  J Tack; M P Jones; G Karamanolis; B Coulie; D Dubois
Journal:  Neurogastroenterol Motil       Date:  2009-02-03       Impact factor: 3.598

7.  The use of pictograms improves symptom evaluation by patients with functional dyspepsia.

Authors:  J Tack; F Carbone; L Holvoet; H Vanheel; T Vanuytsel; A Vandenberghe
Journal:  Aliment Pharmacol Ther       Date:  2014-07-22       Impact factor: 8.171

8.  Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia?

Authors:  S Haag; W Senf; S Tagay; G Heuft; G Gerken; N J Talley; G Holtmann
Journal:  Neurogastroenterol Motil       Date:  2009-10-08       Impact factor: 3.598

9.  Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.

Authors:  Y F Ghoos; B D Maes; B J Geypens; G Mys; M I Hiele; P J Rutgeerts; G Vantrappen
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

10.  The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.

Authors:  Anjiang Wang; XianHua Liao; LiShou Xiong; Sui Peng; YingLian Xiao; SiChun Liu; PinJin Hu; MinHu Chen
Journal:  BMC Gastroenterol       Date:  2008-09-23       Impact factor: 3.067

View more
  38 in total

Review 1.  Functional dyspepsia.

Authors:  Nicholas J Talley; Thomas Goodsall; Michael Potter
Journal:  Aust Prescr       Date:  2017-12-04

2.  Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia.

Authors:  B E Lacy; Y A Saito; M Camilleri; E Bouras; J K DiBaise; L M Herrick; L A Szarka; K Tilkes; A R Zinsmeister; N J Talley
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

3.  Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.

Authors:  Deepti Jacob; Irene Busciglio; Duane Burton; Houssam Halawi; Ibironke Oduyebo; Deborah Rhoten; Michael Ryks; W Scott Harmsen; Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-16       Impact factor: 4.052

4.  Editorial: Moving Away From Focussing on Gastric Pathophysiology in Functional Dyspepsia: New Insights and Therapeutic Implications.

Authors:  Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2017-01       Impact factor: 10.864

5.  A modified Nissen fundoplication: subjective and objective midterm results.

Authors:  Sabrina Rampado; Edoardo Savarino; Angelica Ganss; Giulia Pozza; Romeo Bardini
Journal:  Langenbecks Arch Surg       Date:  2018-03-17       Impact factor: 3.445

Review 6.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

7.  Gastric Motor Dysfunction in Patients With Functional Gastroduodenal Symptoms.

Authors:  Seon-Young Park; Andrés Acosta; Michael Camilleri; Duane Burton; W Scott Harmsen; Jean Fox; Lawrence A Szarka
Journal:  Am J Gastroenterol       Date:  2017-09-12       Impact factor: 10.864

8.  How does one choose the appropriate pharmacotherapy for pediatric patients with functional dyspepsia?

Authors:  M Louai Manini; Michael Camilleri
Journal:  Expert Opin Pharmacother       Date:  2019-08-06       Impact factor: 3.889

Review 9.  New Approaches to Diagnosis and Treatment of Functional Dyspepsia.

Authors:  Toshihiko Tomita; Tadayuki Oshima; Hiroto Miwa
Journal:  Curr Gastroenterol Rep       Date:  2018-10-18

10.  Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores.

Authors:  Brian E Lacy; Kelly Everhart; Michael D Crowell
Journal:  Dig Dis Sci       Date:  2018-10-31       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.